Entia Biosciences, Inc. (ERGO)
OTCMKTS
· Delayed Price · Currency is USD
0.0403
0.00 (0.00%)
At close: Mar 2, 2026
Entia Biosciences Revenue
In the year 2016, Entia Biosciences had annual revenue of $265.47K, down -23.48%. Entia Biosciences had revenue of $45.99K in the quarter ending December 31, 2016, a decrease of -32.77%.
Revenue
265.47K
Revenue Growth
-23.48%
P/S Ratio
5.17
Revenue / Employee
37.92K
Employees
7
Market Cap
1.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2016 | 265.47K | -81.44K | -23.48% |
| Dec 31, 2015 | 346.91K | -309.43K | -47.14% |
| Dec 31, 2014 | 656.34K | 341.60K | 108.53% |
| Dec 31, 2013 | 314.75K | -54.53K | -14.77% |
| Dec 31, 2012 | 369.27K | -34.07K | -8.45% |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
| Dec 31, 2008 | Pro | Pro | Pro |
| Jul 31, 2008 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| International Stem Cell | 9.39M |
| Evofem Biosciences | 17.73M |
| Halberd | 6.94K |
| Eastgate Biotech | 137.64K |
| Carisma Therapeutics | 52.63M |
| Emmaus Life Sciences | 11.89M |